Web Stats Provided By Google Analytics

Wednesday, January 24, 2018

Insider Selling: CymaBay Therapeutics Inc (CBAY) Director Sells 138,253 Shares of Stock

... biopharmaceutical company's stock worth $5,712,000 after acquiring an additional 170,126 shares in the last quarter. Ardsley Advisory Partners raised its stake in CymaBay Therapeutics by 66.2% during the second quarter. Ardsley Advisory Partners now ...
https://sportsperspectives.com/2018/01/24/insider-selling-cymabay-therapeutics-inc-cbay-director-sells-138253-shares-of-stock.html

No comments:

Post a Comment

Popular Ardsley Roundup Posts